Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 7;17(1):20.
doi: 10.1186/s12872-016-0451-8.

Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation

Emmy Okello  1   2   3 , Chris T Longenecker  4 , Andrea Beaton  5 , Moses R Kamya  6 , Peter Lwabi  7
Affiliations

Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation

Emmy Okello et al. BMC Cardiovasc Disord. .

Abstract

Background: Rheumatic heart disease (RHD), the long-term consequence of rheumatic fever, accounts for most cardiovascular morbidity and mortality among young adults in developing countries. However, data on contemporary outcomes from resource constrained areas are limited.

Methods: A prospective cohort study of participants aged 5-60 years with established RHD was conducted in Kampala, Uganda, in which clinical exam, echocardiography, electrocardiography (ECG), and laboratory evaluation were done every 3 months and every 4-week benzathine penicillin prophylaxis was prescribed. Participants were followed up for 12 months and outcomes and predictors of morbidity and mortality were assessed using Kaplan Meier curves and Cox proportional hazards models.

Results: Of 449 subjects, 66.8% (300/449) were females, median age was 30 (interquartile range 20). 73.7% (331/449) had atleast one follow up visit. Among these, 35% (116/331) developed decompensated heart failure and, 63.7% (211/331) developed atrial fibrillation. Heart failure was associated with poor penicillin adherence (OR = 3.3, CI 2-5.4, p = 0.001), and left ventricular end diastolic diameter greater than 55 mm (OR = 3.16, CI 1.73-5.76, p = 0.001). Atrial fibrillation was associated with left atrial diameter >40 mm (OR = 7.5, CI 2.4-9.8, p = 0.001). There were 59 deaths with a 1-year mortality rate of 17.8%. Most deaths occurred within the first three months of presentation. Subjects whose average adherence to benzathine penicillin was <80% had significantly greater mortality (31% vs. 9%, log rank p < 0.001). In multivariate analysis, the risk of death among those with poor penicillin adherence was 3.81 times higher than those with better adherence (HR = 3.81, CI 1.92-7.63, p = 0.001). Other predictors of 1 year mortality included heart failure (HR 8.36, CI 3.28-21.31, p = 0.001) and left ventricular end diastolic diameter greater than 55 mm (HR = 1.93, CI 1.07-3.49, p = 0.02).

Conclusion: In this study of RHD in Uganda, morbidity and mortality within 1 year of presentation were higher than in recently published from other low and middle income countries. Suboptimal adherence to benzathine penicillin injections was associated with incident heart failure and mortality over 1 year. Future studies should test interventions to improve adherence among patients with advanced disease who are at the highest risk of mortality.

Keywords: Morbidity; Mortality; Outcomes; Predictors; Rheumatic heart disease; Uganda.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Morbidity During the First Year Following Initial RHD Presentation
Fig. 2
Fig. 2
Kaplan- Meier curve for mortality within one year of initial presentation with rheumatic heart disease
Fig. 3
Fig. 3
Kaplan Meir curves of participant survival stratified by benzathine penicillin adherence (<80% versus >80%)
See this image and copyright information in PMC

References

    1. Lozano MN, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi: 10.1016/S0140-6736(12)61728-0. - DOI - PMC - PubMed
    1. Roberts KCS, Steer A, Reményi B, Carapetis J. Screening for rheumatic heart disease: current approaches and controversies. Nat Rev Cardiol. 2013;10(1):49–58. doi: 10.1038/nrcardio.2012.157. - DOI - PubMed
    1. Wood H, Feinstein AR, Taranta A, Epstein JA, Simpson R. Rheumatic fever in children and adolescents: a long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae: III. Comparative effectiveness of three prophylaxis regiments in preventing streptococcal infection and rheumatic recurrences. Ann Intern Med. 1964;60:31–46. doi: 10.7326/0003-4819-60-2-31. - DOI
    1. Bland E, Jones T. Rheumatic fever and rheumatic heart disease. A twenty-year report on 1,000 patients followed since childhood. Circulation. 1951;4:836–843. doi: 10.1161/01.CIR.4.6.836. - DOI - PubMed
    1. Tompkins DG, Boxerbaum B, Liebman J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation. 1972;1972:543–551. doi: 10.1161/01.CIR.45.3.543. - DOI - PubMed

Publication types

MeSH terms

Substances